Media More Coverage

Einstein in the Media

CBSNews.com interviews Joel Zonszein, M.D., about a new report that found diabetes-related health complications have declined, including stroke. Dr. Zonszein notes that new medications and increasing educational programs that tackle smoking cessation and nutrition help prevent some diabetes-related complications. Dr. Zonszein is professor of clinical medicine at Albert Einstein College of Medicine and director of the Clinical Diabetes Center at Montefiore Medical Center.

(Friday, April 18, 2014)

 

Contrary to expectations, fish oil doesn't help diabetics' hearts, reports U.S. News & World Report in an article quoting Joel Zonszein, M.D.  Dr. Zonszein advises that diabetics with high LDL, or "bad" cholesterol, should take statins, prescription medications that have been proven to improve cardiovascular outcomes. Dr. Zonszein is professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center.

(Tuesday, June 12, 2012)

 

ABC News.com interviews Joel Zonszein, M.D., about two new trials showing bariatric surgery is an effective treatment for diabetes, lowering blood sugar levels in patients even before the weight comes off. Dr. Zonszein notes that less than two percent of diabetes patients are treated with bariatric or metabolic surgery and that more people can benefit. Dr. Zonszein is  professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center.

(Monday, March 26, 2012)

 

U.S. News & World Report (via Healthday) interviews Joel Zonszein, M.D., on a new study linking type 1 diabetes to risk factors for cardiovascular disease in teenage girls. Researchers found that among those in their study with diabetes, females had higher blood sugar and cholesterol levels and were more overweight — all of which boost the risk of cardiovascular disease — than males. Dr. Zonszein notes that type 1 diabetes may reduce or eliminate the protection women normally demonstrate in their pre-menopausal years. Dr. Joel Zonszein is professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center. (Monday, June 27, 2011)

 

MSN (via HealthDay) interviews Joel Zonszein, M.D., about new research that suggests cold-like viruses may trigger the development of type 1 diabetes in children. Dr. Zonszein, an endocrinologist, notes that the idea that enteroviruses are involved in the development of type 1 diabetes is not new and that while the new research supports an association between the two, it does not prove causality. Dr. Joel Zonszein is professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center. (Friday, February 04, 2011)

 

WebMD interviews Joel Zonszein, M.D., regarding new research that found patients who increased their number of daily steps to 10,000 (about two miles) may reduce their risk of diabetes. After five years, participants who built up to 10,000 steps a day showed a threefold improvement in their insulin sensitivity, when compared with participants who only increased their daily steps to 3,000 per day. Dr. Zonszein notes that although lifestyle changes might be difficult to maintain, these results illustrate the benefits for reducing diabetes risk. Dr. Joel Zonszein is professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center. (Friday, January 14, 2011)

 

Bloomberg BusinessWeek (via HealthDay) interviews Joel Zonszein, M.D., about diabetes prevention and treatment in honor of World Diabetes Day. Dr. Zonszein notes that prevention is key. For those at risk for diabetes, or in the early stages of the disease, modest changes in diet and exercise can delay the onset or progression of the disease. Dr. Joel Zonszein is professor of clinical medicine at Einstein and director of the Clinical Diabetes Center at Montefiore Medical Center. (Thursday, November 11, 2010)

More coverage on other stories